While previous studies have revealed the tumor-promoting role of EHF in thyroid and ovarian cancer [16,17], EHF inhibits the invasion and metastasis of pancreatic cancer cells by directly binding to the EBS in the promoter region of the E-cadherin gene and upregulating its expression. Here, CDH1 is linked to pancreatic neoplasm.